Sanofi, GSK to seek approval for COVID vaccine candidate

  • Seeking approval as primary vaccine regimen and booster dose
  • Full trial results expected to be published later this year
  • Two doses 100% effective against severe COVID-19
  • Booster dose boosts neutralizing antibodies across platforms

PARIS, Feb 23 (Reuters) – French drugmaker Sanofi (SASY.PA) and its British partner GlaxoSmithKline (GSK.L) are seeking regulatory approval for their COVID-19 vaccine to…

Continue Reading

News Source:

Leave a comment

Your email address will not be published.